Escape of human immunodeficiency virus from immune control.
about
Antiviral actions of interferonsAssessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivoNarrowing the Gap: Preserving Repertoire Diversity Despite Clonal Selection during the CD4 T Cell ResponseEffective T helper cell responses against retroviruses: are all clonotypes equal?Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitisUnusual distribution of mutations associated with serial bottleneck passages of human immunodeficiency virus type 1Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell DeterminantEmerging epidemic diseases of frogs in Britain are dependent on the source of ranavirus agent and the route of exposureAnnulling a dangerous liaison: vaccination strategies against AIDS and tuberculosisHIV-1 Env C2-V4 diversification in a slow-progressor infant reveals a flat but rugged fitness landscapeMonocytes contribute to differential immune pressure on R5 versus X4 HIV through the adipocytokine visfatin/NAMPTMHC signaling during social communicationAn endogenous HIV envelope-derived peptide without the terminal NH3+ group anchor is physiologically presented by major histocompatibility complex class I molecules.Inhibition of adaptive immune responses leads to a fatal clinical outcome in SIV-infected pigtailed macaques but not vervet African green monkeys.High throughput T epitope mapping and vaccine developmentThe cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant.Frequent associations between CTL and T-Helper epitopes in HIV-1 genomes and implications for multi-epitope vaccine designsImmunologic pressure within class I-restricted cognate human immunodeficiency virus epitopes during highly active antiretroviral therapyProtection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cellsGenetic variation in the odorant receptors family 13 and the mhc loci influence mate selection in a multiple sclerosis datasetRapid induction of IgE responses to a worm cysteine protease during murine pre-patent schistosome infectionInfection with cytotoxic T-lymphocyte escape mutants results in increased mortality and growth retardation in mice infected with a neurotropic coronavirus.Development of an in vivo assay to identify structural determinants in murine leukemia virus reverse transcriptase important for fidelityT-cell receptor-mediated anergy of a human immunodeficiency virus (HIV) gp120-specific CD4(+) cytotoxic T-cell clone, induced by a natural HIV type 1 variant peptide.Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiencyAntigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.During readaptation in vivo, a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein.Perforin and Fas cytolytic pathways coordinately shape the selection and diversity of CD8+-T-cell escape variants of influenza virus.In vitro human immunodeficiency virus eradication by autologous CD8(+) T cells expanded with inactivated-virus-pulsed dendritic cells.Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine designMemory CD8+ T cells in HIV infectionFunctional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytesHIV-1 envelope proteins and V1/V2 domain scaffolds with mannose-5 to improve the magnitude and quality of protective antibody responses to HIV-1Transduction of SIV-specific TCR genes into rhesus macaque CD8+ T cells conveys the ability to suppress SIV replication.Immunological transitions in response to antigenic mutation during viral infection.Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy.Genetic and stochastic influences on the interaction of human immunodeficiency virus type 1 and cytotoxic T lymphocytes in identical twins.On the origin and evolution of the human immunodeficiency virus (HIV).Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection
P2860
Q24550676-C53A0126-EFE6-4243-AC75-5B50FDA81DC6Q24801797-367B43E7-6896-4982-BD22-BE0A5FDB3E61Q25255777-AA8F623A-54A6-4B7B-810F-B93CD2B8C114Q26796086-7105FCF5-9D1D-4ED9-AC2F-38269B988005Q26995251-98C1C5D4-C228-4B83-91CD-9DBF9D175296Q27469459-6907BAC6-5CDF-4895-B83A-8A8F8B9FEFEAQ27469694-68AE3C1C-CC3E-49A7-A1C5-AD6CC213608FQ27652640-15FE9152-20A9-4922-A547-96558B1E6223Q27727994-7CCEE5C5-F87B-4827-AE86-E3B7410510BDQ28243702-1C73DCE8-0AC6-46A4-8371-D27CDC3AB9D4Q28487168-5D16883C-E4A8-473C-8994-2905D34573EFQ28730721-634EA735-F293-488D-8B28-F651ADEA82FDQ28834594-06944256-CCAC-4835-AE9B-59B4BCF16B51Q31019004-3457F0A9-2ED0-4BC2-98E0-C576390418F3Q33518502-A157FB57-8789-4E03-A179-34D6422F2B8BQ33628719-0C46C2B0-5F4D-4F5B-8C63-6AB8C4A71A42Q33650076-A07D4307-872C-42A2-BA5C-9DC802D9874AQ33652911-122D405A-9C05-48BE-9C0E-A9BF529D1C0CQ33737646-A6C8BFC0-4F47-4BAB-94DF-2ED72583E611Q33737723-5294A8B4-B241-4B44-A2D3-F22D5C6CDF07Q33743660-BF61571F-8555-4D06-8C8C-850F0DDF9B11Q33747036-0EBF575E-2A53-46DA-A7A9-8CC56E4380D5Q33785674-5F3203DC-4124-4790-B414-3FC9E0B51054Q33794922-150B33D8-189E-4199-9EA7-98165856AC99Q33798409-0EB2C274-4551-49EB-86FF-EB1C61B7EED2Q33803446-FD460955-9E95-427A-BED2-0F7053BE22DAQ33808561-89B64642-E181-45E7-80EE-5EADD3C51C47Q33840406-32C0992F-5464-45F1-866B-2BB40AEEB13DQ33843485-BFA487E2-6B00-49E1-A1C7-EF391B778B10Q33845018-B49D8E6D-E98B-4EBC-BB45-DDE9A9912110Q33845527-7656B46B-F558-4E62-9B78-096B8889249FQ33905214-9EEE899F-7522-4194-9555-463F0DCC2BC7Q33930372-391B22F1-8F58-456B-98A0-AF93A55A5C94Q33947008-43C4D177-30AE-4A10-8DB5-69FF47B86616Q34008900-F9ED2627-408C-494B-B81A-9CC050CACE8BQ34047035-CCB4C6F9-D9AC-449F-A3ED-05E8211C1F22Q34067437-4F90DCE6-8561-40C8-8722-BAFD480442D6Q34228633-C5C43C0F-E483-4771-B482-58777FAAF715Q34276664-5BFE0482-B8F2-4C90-BE96-D6EAE89F76E3Q34295972-09705819-4197-4319-A140-77108BF5E4D4
P2860
Escape of human immunodeficiency virus from immune control.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Escape of human immunodeficiency virus from immune control.
@en
type
label
Escape of human immunodeficiency virus from immune control.
@en
prefLabel
Escape of human immunodeficiency virus from immune control.
@en
P1476
Escape of human immunodeficiency virus from immune control.
@en
P2093
McMichael AJ
Phillips RE
P304
P356
10.1146/ANNUREV.IMMUNOL.15.1.271
P577
1997-01-01T00:00:00Z